We are live on ! Find out more
PHS

Pekin Hardy Strauss Portfolio holdings

AUM $1.14B
1-Year Est. Return 37.36%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+37.36%
3 Year Est. Return
+102.22%
5 Year Est. Return
+128.49%
10 Year Est. Return
+410.17%
AUM
$804M
AUM Growth
+$65.3M
Cap. Flow
+$16.7M
Cap. Flow %
2.08%
Top 10 Hldgs %
29.66%
Holding
373
New
39
Increased
99
Reduced
135
Closed
43

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$4.46M
2
CCJ icon
Cameco
CCJ
+$3.58M
3
PHYS icon
Sprott Physical Gold
PHYS
+$3.48M
4
EVR icon
Evercore
EVR
+$3.45M
5
META icon
Meta Platforms (Facebook)
META
+$3.35M

Sector Composition

Rank Sector Weight
1 Energy 10.56%
2 Technology 8.81%
3 Materials 8.7%
4 Financials 8.52%
5 Consumer Staples 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
226
PayPal
PYPL
$50.5B
$444K 0.06%
3,835
-4,949
-56% -$659K
ITEQ icon
227
Amplify BlueStar Israel Technology ETF
ITEQ
$119M
$441K 0.05%
7,875
-1,070
-12% -$59.1K
CHPT icon
228
ChargePoint
CHPT
$161M
$437K 0.05%
+1,100
New +$339K
MLPA icon
229
Global X MLP ETF
MLPA
$2.26B
$434K 0.05%
+10,765
New +$419K
IEX icon
230
IDEX
IEX
$17.3B
$431K 0.05%
2,250
CLR
231
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$423K 0.05%
+6,900
New +$383K
UTF icon
232
Cohen & Steers Infrastructure Fund
UTF
$3.04B
$422K 0.05%
14,590
PFF icon
233
iShares Preferred and Income Securities ETF
PFF
$13.3B
$420K 0.05%
11,529
-65,496
-85% -$2.41M
XBI icon
234
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$420K 0.05%
+4,668
New +$431K
ULTA icon
235
Ulta Beauty
ULTA
$24.3B
$416K 0.05%
1,045
WY icon
236
Weyerhaeuser
WY
$18.4B
$415K 0.05%
10,948
+2,100
+24% +$83.3K
JLS icon
237
Nuveen Mortgage and Income Fund
JLS
$94.7M
$414K 0.05%
22,680
-2,400
-10% -$46.5K
ELV icon
238
Elevance Health
ELV
$85.5B
$413K 0.05%
840
-14,305
-94% -$6.54M
BP icon
239
BP
BP
$107B
$412K 0.05%
14,027
-25,825
-65% -$787K
MJ icon
240
Amplify Alternative Harvest ETF
MJ
$105M
$410K 0.05%
3,295
-750
-19% -$90.2K
MSD
241
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$409K 0.05%
52,600
-1,800
-3% -$14.9K
VEU icon
242
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$406K 0.05%
7,051
+166
+2% +$9.77K
MHK icon
243
Mohawk Industries
MHK
$9.22B
$402K 0.05%
3,235
+810
+33% +$121K
GILD icon
244
Gilead Sciences
GILD
$165B
$401K 0.05%
6,750
-1,000
-13% -$63.9K
MSTR icon
245
Strategy Inc
MSTR
$38.4B
$395K 0.05%
8,120
-6,400
-44% -$277K
WBA
246
DELISTED
Walgreens Boots Alliance
WBA
$395K 0.05%
8,829
-90
-1% -$4.43K
FINS
247
Angel Oak Financial Strategies Income Term Trust
FINS
$421M
$391K 0.05%
24,790
+3,000
+14% +$48.8K
AGG icon
248
iShares Core US Aggregate Bond ETF
AGG
$138B
$377K 0.05%
3,517
+554
+19% +$61K
COPX icon
249
Global X Copper Miners ETF NEW
COPX
$8.16B
$377K 0.05%
8,290
GSK icon
250
GSK
GSK
$106B
$372K 0.05%
6,825
+120
+2% +$6.52K

Similar funds

Pekin Hardy Strauss's Q1 2022 Portfolio in Review

As of Q1 2022, Pekin Hardy Strauss held 373 positions worth $804M, up 8.8% from $739M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Pekin Hardy Strauss's Q1 2022 filing shows 39 new, 99 increased, 135 reduced and 43 closed positions. Its largest new stake was Fiserv Inc: 44,046 shares worth $4.47M. The largest sale was KraneShares Global Carbon Strategy ETF, an estimated $11.2M.

By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 7.4% a quarter earlier, followed by Technology and Materials.

  • Pekin Hardy Strauss's largest Q1 2022 buy was Fiserv Inc: 44,046 shares worth $4.47M.
  • Pekin Hardy Strauss added most to Cameco in Q1 2022, an estimated $3.58M increase.
  • Pekin Hardy Strauss's biggest Q1 2022 reduction was Elevance Health, cutting an estimated $6.54M.
  • Pekin Hardy Strauss fully exited KraneShares Global Carbon Strategy ETF in Q1 2022, selling an estimated $11.2M.
  • Pekin Hardy Strauss's ten largest holdings make up 30% of its $804M portfolio in Q1 2022.
  • Pekin Hardy Strauss opened 39 new positions and closed 43 in Q1 2022.
  • Pekin Hardy Strauss's portfolio value rose 8.8% quarter-over-quarter to $804M.

Based on Pekin Hardy Strauss's 13F filing for Q1 2022, filed 13 May 2022.